Syndax Medical Affairs
Ask a Question
Clinical Trials
Disease Information
Find your MSL
Footer
Header
Publications
Resources
Syndax Medical Affairs
Revumenib – AE Management Standard Response Letter
adverse; adverse event; adverse event management; management; differentiation; syndrome; qt; qtc
February 22, 2025